Reaction

Metastases To Meninges reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,213 reports · 84 co-occurring drugs

As of the last recalculation, Metastases To Meninges appears in 2,213 FAERS reports alongside 84 co-occurring drug terms. The strongest observed disproportionality signal is GEFITINIB (PRR 129.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Gefitinib	118	129.8	131.5
Osimertinib	307	104.4	105.4
Fam-Trastuzumab Deruxtecan-Nxki	45	42.8	43.0
Erlotinib	38	37.5	37.7
Erlotinib Hydrochloride	42	32.2	32.3
Dabrafenib	60	27.5	27.6
Trametinib	63	25.2	25.3
Pemetrexed	54	24.3	24.3
Pertuzumab	65	23.1	23.2
Ado-Trastuzumab Emtansine	19	21.4	21.4
Trastuzumab	137	19.9	20.0
Pemetrexed Disodium	77	19.7	19.7
Paclitaxel (Aibumin-Bound)	151	18.5	18.5
Goserelin	26	18.4	18.5
Temozolomide	40	18.2	18.2
Paclitaxel	175	18.0	18.0
Bevacizumab	210	17.5	17.5
Atezolizumab	67	16.7	16.7
Fulvestrant	57	16.6	16.7
Carboplatin	202	16.4	16.4
Letrozole	99	15.8	15.8
Letrozole Tablets	76	15.4	15.4
Lapatinib	25	15.3	15.3
Exemestane	34	15.1	15.2
Polatuzumab Vedotin	15	14.5	14.6
Ifosfamide	32	14.2	14.2
Capecitabine	128	13.9	13.9
Olaparib	30	13.7	13.7
Crizotinib	18	13.4	13.4
Docetaxel Anhydrous	88	12.7	12.8
Docetaxel	88	12.7	12.8
Vemurafenib	16	12.6	12.6
Everolimus Tablets	21	11.9	11.9
Bendamustine Hcl	19	11.6	11.6
Thiotepa	11	10.9	10.9
Ampicillin	9	10.3	10.3
Ampicillin Sodium	9	10.3	10.3
Oxaliplatin	78	10.2	10.2
Gemcitabine	42	10.2	10.2
Etoposide	77	10.2	10.2
Doxorubicin	87	9.5	9.5
Gemcitabine Hydrochloride	52	9.4	9.4
Durvalumab	20	9.3	9.3
Cisplatin	75	9.3	9.3
Ribociclib	30	9.0	9.1
Nivolumab	85	8.6	8.6
Ipilimumab	38	8.4	8.4
Everolimus	44	8.3	8.3
Cytarabine	49	7.8	7.8
Cyclophosphamide Injection, Solution	135	7.6	7.6
Cyclophosphamide	135	7.6	7.6
Cyclophosphamide For Injection	135	7.6	7.6
Obinutuzumab	13	7.5	7.5
Leucovorin Calcium	15	7.4	7.4
Doxorubicin Hydrochloride	24	7.0	7.0
Memantine	10	6.9	6.9
Memantine Hydrochloride	10	6.9	6.9
Dexamethasone Sodium Phosphate	7	6.5	6.5
Zoledronic Acid	26	6.2	6.2
Vincristine Sulfate	19	6.1	6.1
Encorafenib	6	5.7	5.7
Mesna Injection	5	5.7	5.7
Mesna	5	5.6	5.6
Pembrolizumab	61	5.6	5.6
Alpelisib	5	5.4	5.4
Fluorouracil Cream, 0.5%	42	5.3	5.3
Fluorouracil	42	5.2	5.2
Prochlorperazine Maleate	5	5.1	5.1
Dexamethasone 1.5 Mg	142	4.8	4.8
Fosaprepitant Dimeglumine	7	4.8	4.8
Dexamethasone	142	4.7	4.7
Blinatumomab	5	4.5	4.5
Granisetron	5	4.5	4.5
Irinotecan Hydrochloride	6	4.4	4.4
Denosumab	86	4.1	4.1
Bendamustine Hydrochloride	5	3.9	3.9
Lutetium Lu 177 Vipivotide Tetraxetan	5	3.6	3.6
Cabozantinib	17	3.3	3.3
Cetuximab	11	3.3	3.3
Palbociclib	29	2.9	2.9
Axicabtagene Ciloleucel	3	2.9	2.9
Venetoclax	18	2.8	2.8
Abiraterone Acetate	10	2.3	2.3
Pegfilgrastim	16	1.5	1.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.